MENU
AMAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ambrx Biopharma (AMAM) Ownership - Who owns Ambrx Biopharma?

Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells... Show more

Profile

Industry
N/A
Address
10975 North Torrey Pines Road
Phone
+1 858 875-2400
Employees
66
Web
https://www.ambrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.77B
P/E Ratio
66.64
Total Cash
225.26M
Projected Growth
N/A
Total Debt
10.52M
Revenue
4.09M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.56
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
10975 North Torrey Pines Road
Phone
+1 858 875-2400
Employees
66
Web
https://www.ambrx.com